These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 23897824)
1. SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region. Mameza MG; Dvoretskova E; Bamann M; Hönck HH; Güler T; Boeckers TM; Schoen M; Verpelli C; Sala C; Barsukov I; Dityatev A; Kreienkamp HJ J Biol Chem; 2013 Sep; 288(37):26697-708. PubMed ID: 23897824 [TBL] [Abstract][Full Text] [Related]
2. Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus. Hassani Nia F; Woike D; Martens V; Klüssendorf M; Hönck HH; Harder S; Kreienkamp HJ Mol Autism; 2020 Oct; 11(1):85. PubMed ID: 33115499 [TBL] [Abstract][Full Text] [Related]
3. The Shank/ProSAP N-Terminal (SPN) Domain of Shank3 Regulates Targeting to Postsynaptic Sites and Postsynaptic Signaling. Woike D; Tibbe D; Hassani Nia F; Martens V; Wang E; Barsukov I; Kreienkamp HJ Mol Neurobiol; 2024 Feb; 61(2):693-706. PubMed ID: 37656313 [TBL] [Abstract][Full Text] [Related]
4. Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders. Woike D; Wang E; Tibbe D; Hassani Nia F; Failla AV; Kibæk M; Overgård TM; Larsen MJ; Fagerberg CR; Barsukov I; Kreienkamp HJ Sci Rep; 2022 Jan; 12(1):902. PubMed ID: 35042901 [TBL] [Abstract][Full Text] [Related]
5. Functional Relevance of Missense Mutations Affecting the N-Terminal Part of Shank3 Found in Autistic Patients. Hassani Nia F; Kreienkamp HJ Front Mol Neurosci; 2018; 11():268. PubMed ID: 30131675 [TBL] [Abstract][Full Text] [Related]
6. Autism-associated Bucher M; Niebling S; Han Y; Molodenskiy D; Hassani Nia F; Kreienkamp HJ; Svergun D; Kim E; Kostyukova AS; Kreutz MR; Mikhaylova M Elife; 2021 May; 10():. PubMed ID: 33945465 [TBL] [Abstract][Full Text] [Related]
7. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. Arons MH; Thynne CJ; Grabrucker AM; Li D; Schoen M; Cheyne JE; Boeckers TM; Montgomery JM; Garner CC J Neurosci; 2012 Oct; 32(43):14966-78. PubMed ID: 23100419 [TBL] [Abstract][Full Text] [Related]
8. Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Lim S; Sala C; Yoon J; Park S; Kuroda S; Sheng M; Kim E Mol Cell Neurosci; 2001 Feb; 17(2):385-97. PubMed ID: 11178875 [TBL] [Abstract][Full Text] [Related]
9. Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies. Sarowar T; Grabrucker AM Neural Plast; 2016; 2016():8051861. PubMed ID: 27795858 [TBL] [Abstract][Full Text] [Related]
10. Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin. Böckers TM; Mameza MG; Kreutz MR; Bockmann J; Weise C; Buck F; Richter D; Gundelfinger ED; Kreienkamp HJ J Biol Chem; 2001 Oct; 276(43):40104-12. PubMed ID: 11509555 [TBL] [Abstract][Full Text] [Related]
11. An N-terminal and ankyrin repeat domain interactome of Shank3 identifies the protein complex with the splicing regulator Nono in mice. Okuzono S; Fujii F; Setoyama D; Taira R; Shinmyo Y; Kato H; Masuda K; Yonemoto K; Akamine S; Matsushita Y; Motomura Y; Sakurai T; Kawasaki H; Han K; Kato TA; Torisu H; Kang D; Nakabeppu Y; Ohga S; Sakai Y Genes Cells; 2024 Sep; 29(9):746-756. PubMed ID: 38964745 [TBL] [Abstract][Full Text] [Related]
12. Shank3 deficiency elicits autistic-like behaviors by activating p38α in hypothalamic AgRP neurons. Wu S; Wang J; Zhang Z; Jin X; Xu Y; Si Y; Liang Y; Ge Y; Zhan H; Peng L; Bi W; Luo D; Li M; Meng B; Guan Q; Zhao J; Gao L; He Z Mol Autism; 2024 Apr; 15(1):14. PubMed ID: 38570876 [TBL] [Abstract][Full Text] [Related]
14. Abnormal neuronal morphology and altered synaptic proteins are restored by oxytocin in autism-related SHANK3 deficient model. Reichova A; Bacova Z; Bukatova S; Kokavcova M; Meliskova V; Frimmel K; Ostatnikova D; Bakos J Mol Cell Endocrinol; 2020 Dec; 518():110924. PubMed ID: 32619581 [TBL] [Abstract][Full Text] [Related]
15. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Bangash MA; Park JM; Melnikova T; Wang D; Jeon SK; Lee D; Syeda S; Kim J; Kouser M; Schwartz J; Cui Y; Zhao X; Speed HE; Kee SE; Tu JC; Hu JH; Petralia RS; Linden DJ; Powell CM; Savonenko A; Xiao B; Worley PF Cell; 2011 May; 145(5):758-72. PubMed ID: 21565394 [TBL] [Abstract][Full Text] [Related]
16. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Durand CM; Perroy J; Loll F; Perrais D; Fagni L; Bourgeron T; Montcouquiol M; Sans N Mol Psychiatry; 2012 Jan; 17(1):71-84. PubMed ID: 21606927 [TBL] [Abstract][Full Text] [Related]
17. The association of SHANK3 gene polymorphism and autism. Mashayekhi F; Mizban N; Bidabadi E; Salehi Z Minerva Pediatr (Torino); 2021 Jun; 73(3):251-255. PubMed ID: 27271042 [TBL] [Abstract][Full Text] [Related]
18. Impaired synaptic function and hyperexcitability of the pyramidal neurons in the prefrontal cortex of autism-associated Shank3 mutant dogs. Zhu F; Shi Q; Jiang YH; Zhang YQ; Zhao H Mol Autism; 2024 Jan; 15(1):9. PubMed ID: 38297387 [TBL] [Abstract][Full Text] [Related]